http://rdf.ncbi.nlm.nih.gov/pubchem/patent/IL-232897-B

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b01dcd61775e996fac631d4b10c4e87f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5719009c9f5cdf3fdb81eb2348aa5cb8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c0f4602b52c9d137a9a729a91251de85
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-445
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4458
filingDate 2014-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2019-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber IL-232897-B
titleOfInvention Pacetopran for the treatment of attention, concentration and hyperactivity disorder
priorityDate 2011-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15706387
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419591235

Total number of triples: 17.